Heart rate predicts mortality in patients with heart failure and preserved systolic function

J Card Fail. 2010 Oct;16(10):806-11. doi: 10.1016/j.cardfail.2010.04.013. Epub 2010 Jun 16.

Abstract

Background: Elevated resting heart rates have been associated with increased mortality and morbidity in patients with heart failure and decreased left ventricular ejection fraction (EF). It is unclear, though, if this association applies to those with heart failure and preserved EF.

Methods and results: We determined outcome for 685 consecutive patients with a prior diagnosis of heart failure and a preserved EF (>50%) documented on echocardiography at 1 of 3 laboratories. Patients with non-sinus rhythm were excluded from the analysis. We determined adjusted mortality rates at 1 year after the echocardiogram. The mean age of the cohort was 70 ± 11 years. Of the 685 included patients, 87% had a history of hypertension, 50% had diabetes, and the mean EF was 60% ± 6%. All-cause mortality at 1 year was significantly lower in the group with heart rate below 60 beats/min (10%) when compared with the group with heart rates between 60 and 70 beats/min (18%), 71-90 beats/min (20%), and >90 beats/min (35%) (P < .0001). After adjustment for patient history, demographics, laboratory values, and echocardiographic findings, the hazard ratios for total mortality (relative to a heart rate of <60) were 1.26 (95% CI, 0.88-1.80) for HR 60-69, 1.47 (95% CI, 1.02-2.07) for HR 70-90, and 2.00 (95% CI, 1.31-3.04) for HR>90 (P = .01 across all groups).

Conclusions: These data suggest that an elevated resting heart rate is a marker for increased mortality in patients with heart failure and preserved systolic function. Heart rate may be useful in these patients for improved cardiovascular risk assessment.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Cardiovascular Agents / therapeutic use
  • Diabetes Complications / physiopathology
  • Echocardiography
  • Female
  • Heart Failure / complications
  • Heart Failure / diagnosis*
  • Heart Failure / mortality*
  • Heart Failure / physiopathology*
  • Heart Failure / therapy
  • Heart Rate*
  • Hospitalization
  • Humans
  • Hypertension / complications
  • Kaplan-Meier Estimate
  • Life Expectancy
  • Male
  • Middle Aged
  • Prognosis
  • Risk Assessment / statistics & numerical data
  • Stroke Volume / physiology*
  • Ventricular Function, Left / physiology

Substances

  • Cardiovascular Agents